• Extended-release injection shows promise for bilateral knee OA

    14 days ago - By Healio

    CHICAGO - An intra-articular injection of extended-release triamcinolone acetonide administered to both knees of patients with bilateral knee osteoarthritis was associated with a 10-fold reduction in drug plasma concentrations compared with traditional immediate-release triamcinolone acetonide, according to results of a phase 2 trial.
    The findings are consistent with previous research demonstrating a prolonged benefit of triamcinolone acetonide extended-release - approved by the FDA last year for knee OA pain -among patients with
    Read more ...